ArticlePharmaceutics2025

Physiologically Based Biopharmaceutics Model of Apixaban for Biopharmaceutics Risk Assessment.

Paulo Paixão et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.